Metzger Michael A

Metzger Michael A is listed in filings as Chief Executive Officer at Syndax Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity. Recent filings connect the profile to Syndax Pharmaceuticals, Inc. (SNDX) and Pyxis Oncology, Inc. (PYXS). The current snapshot covers public activity from Jun 10, 2024 to Jun 2, 2026. Reported amounts are shown as $130.0K to $360.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.